Thomson Medical Group Ltd. (3H5) Stock Statistics & Valuation Metrics

Thomson Medical Group Ltd. has a market cap or net worth of EUR 875.89M. The enterprise value is EUR 2.47B.

Market Cap

EUR 875.89M

Enterprise Value

EUR 2.47B

Thomson Medical Group Ltd. has 26,443,615,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

26,443,615,000

Owned by Insiders

<0.01%

Owned by Institutions

0.05%

Thomson Medical Group Ltd.’s return on equity (ROE) is -0.07 and return on invested capital (ROIC) is 1.57%.

Return on Equity (ROE)

-0.07

Return on Assets (ROA)

-0.02

Return on Invested Capital (ROIC)

1.57%

Return on Capital Employed (ROCE)

0.02

Revenue Per Employee

192.26K

Profits Per Employee

-13.59K

Employee Count

2,185

Asset Turnover

0.24

Inventory Turnover

0.75

The current PE Ratio of Thomson Medical Group Ltd. is -40.27. Thomson Medical Group Ltd.’s PEG ratio is -1.01.

PE Ratio

-40.27

PS Ratio

2.91

PB Ratio

2.82

Price to FCF

22.34

Price to Operating Cash Flow

17.56

PEG Ratio

-1.01

In the last 12 months, Thomson Medical Group Ltd. had revenue of 420.08M and earned -29.70M in profits. Earnings per share was -0.00.

Revenue

420.08M

Gross Profit

309.86M

Operating Income

26.30M

Pretax Income

-21.13M

Net Income

-29.70M

EBITDA

69.06M

Earnings Per Share (EPS)

-0.00

In the last 12 months, operating cash flow was 70.96M and capital expenditures -15.32M, giving a free cash flow of 55.64M billion.

Operating Cash Flow

70.96M

Free Cash Flow

55.64M

Free Cash Flow per Share

0.00

Thomson Medical Group Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

4.48%

Earnings Yield

-2.38%

Beta

0.23

52-Week Price Change

-13.51%

50-Day Moving Average

0.03

200-Day Moving Average

0.04

Relative Strength Index (RSI)

34.80

Average Volume (3m)

―

Thomson Medical Group Ltd. upcoming earnings date is Nov 18, 2026, TBA (Not Confirmed).

Last Earnings Date

Aug 26, 2026

Next Earnings Date

Nov 18, 2026

Ex-Dividend Date

―

Thomson Medical Group Ltd. as a current ratio of 1.04, with Debt / Equity ratio of 255.42%

Current Ratio

1.04

Quick Ratio

0.57

Debt to Market Cap

0.80

Net Debt to EBITDA

14.72

Interest Coverage Ratio

0.53

In the past 12 months, Thomson Medical Group Ltd. has paid 6.67M in taxes.

Income Tax

6.67M

Effective Tax Rate

-0.32

Thomson Medical Group Ltd. EV to EBITDA ratio is 27.69, with an EV/FCF ratio of 41.61.

EV to Sales

5.43

EV to EBITDA

27.69

EV to Free Cash Flow

41.61

EV to Operating Cash Flow

32.63

Thomson Medical Group Ltd. has EUR 105.11M in cash and marketable securities with EUR 1.13B in debt, giving a net cash position of -EUR 1.03B billion.

Cash & Marketable Securities

EUR 105.11M

Total Debt

EUR 1.13B

Net Cash

-EUR 1.03B

Net Cash Per Share

-EUR 0.04

Tangible Book Value Per Share

-EUR 0.01

Gross margin is 41.14%, with operating margin of 6.16%, and net profit margin of -6.96%.

Gross Margin

41.14%

Operating Margin

6.16%

Pretax Margin

-4.95%

Net Profit Margin

-6.96%

EBITDA Margin

19.60%

EBIT Margin

9.74%

The average price target for Thomson Medical Group Ltd. is EUR 0.05, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

EUR 0.05

Price Target Upside

54.16% Upside

Analyst Consensus

Moderate Buy

Analyst Count

1

Revenue Growth Forecast

2.39%

EPS Growth Forecast

33.33%